Warren Stone
Chief Executive Officer (effective January 4, 2027); President and Chief Operating Officer (current), NEOGENOMICS INC · United States
Warren Stone is the CEO of NEOGENOMICS INC (NEO). Stone is based in the United States.
Warren Stone is a life sciences and diagnostics leader with over 30 years of experience in general management and commercial leadership. He joined NeoGenomics in November 2022 and has held progressively senior roles including President of Clinical Services, Chief Commercial Officer, and President and Chief Operating Officer, and was appointed CEO effective January 4, 2027. Previously, he served as President of Commercial Americas at Ortho Clinical Diagnostics and in various senior roles at MilliporeSigma/Merck KGaA.
Recent developments
AI summary of recent coverageRecent coverage has focused on NeoGenomics' appointment of Warren Stone as chief executive officer, with Stone set to assume the role effective January 4, 2027. The announcement was accompanied by the company's disclosure of third-quarter revenue guidance and details regarding an executive leadership and board succession plan. Earlier reporting also covered company developments including acquisitions aimed at expanding cancer testing capabilities and stock transactions by NeoGenomics' chief operating officer.
Summarized from the headlines below; see each source for the full story.
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Warren Stone, it will appear here — and tie into the news timeline.
Warren Stone: FAQ
- Who is Warren Stone?
- Warren Stone is the Chief Executive Officer (effective January 4, 2027); President and Chief Operating Officer (current) of NEOGENOMICS INC, based in United States.
- What company does Warren Stone lead?
- Warren Stone is CEO of NEOGENOMICS INC.